Education
About Us
Working with TipRanks
Follow Us
Monash IVF Group Ltd (AU:MVF)
ASX:MVF
MVF Stock Chart & Stats
AU$0.68
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.68
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.54 - AU$1.23
Previous CloseN/A
Volume300.99K
Average Volume (3M)2.18M
Market Cap
AU$276.64M
Enterprise ValueAU$451.42M
Total Cash (Recent Filing)AU$9.43M
Total Debt (Recent Filing)AU$180.31M
Price to Earnings (P/E)11.1
Beta1.22
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield6.22%
Share Statistics
EPS (TTM)N/A
Shares Outstanding389,634,830
10 Day Avg. Volume1,374,502
30 Day Avg. Volume2,181,726
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.81Price Target Upside19.12% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recent Revenue SurgeA 74.5% revenue increase in the latest year indicates materially improving demand and utilisation across clinics and labs. This scale uplift supports durable service mix expansion, improves capacity leverage and underpins medium-term reinvestment in operations and clinical capability.
Healthy Profit MarginsSustained gross margin (33.2%) and net margin (9.2%) reflect pricing power and efficient clinical/lab operations. Margin levels in specialized fertility services provide a structural buffer versus general healthcare, supporting profitability resilience through cost cycles and enabling funding for growth initiatives.
Balanced Capital StructureA moderate D/E of 0.73 with ROE at 10.2% signals prudent leverage and effective equity use. This balance gives the company financing flexibility to invest in clinic rollout or labs while maintaining financial stability, reducing refinancing risk over the next several quarters.
Bears Say
Severe Free Cash Flow DeclineA 96.4% drop in free cash flow and an OCF-to-net-income ratio of 0.21 show weak cash conversion despite reported profits. This constrains capex, working capital flexibility and dividend coverage, and raises funding risk if earnings normalise slowly or working capital needs remain elevated.
Margin VolatilityObserved swings in EBIT/EBITDA margins indicate earnings sensitivity to case mix, clinic utilisation and cost timing. Persistent volatility reduces predictability of cash flow and ROI on new clinics, complicating medium-term planning and potentially increasing the cost of capital for expansion.
Exposure To Reimbursement & Referral DynamicsRevenue dependence on reimbursement policies, insurer coverage and GP/specialist referrals makes demand vulnerable to regulatory or payer shifts. Such structural externalities can materially affect patient affordability, volumes and long-term growth prospects across the clinic network.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.54 and its highest was AU$1.23 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$276.64M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 26, 2026 which is in 187 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Currently, no data Available
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Semiannually dividend of AU$0.026 which represents an annual dividend yield of 6.22%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.81 (19.12% Upside)
AU$0.81 (19.12% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 89%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth AU$53.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
10.25%
Trailing 12-Months
Asset Growth
-3.12%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.81
▲(19.12% Upside)
Technical Analysis
Healius Limited
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---